The Lancet, Volume 369, Issue 9578
, Pages 2021 - 2029, 16 June 2007
doi:10.1016/S0140-6736(07)60942-8Cite or Link Using DOI
This article can be found in the following collections: Infectious Diseases (Infectious diseases-other)
Copyright © 2007 Elsevier Ltd All rights reserved.
Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study
Ivermectin has been used for onchocerciasis control since 1987. Because of the long-term use of this drug and the development of resistance in other nematodes, we have assessed Onchocerca volvulus burdens, effectiveness of ivermectin as a microfilaricide, and its effect on adult female worm reproduction.
For the first phase of the study, 2501 individuals in Ghana, from 19 endemic communities who had received six to 18 annual rounds of ivermectin and one ivermectin naive community, were assessed for microfilarial loads 7 days before the 2004 yearly ivermectin treatment, by means of skin snips, and 30 days after treatment to assess the ivermectin microfilaricidal action. For the second phase, skin snips were taken from 342 individuals from ten communities, who were microfilaria positive at pretreatment assessment, on days 90 and 180 after treatment, to identify the effects of ivermectin on female worm fertility, assessed by microfilaria repopulation.
487 (19%) of the 2501 participants were microfilaria positive. The microfilaria prevalence and community microfilarial load in treated communities ranged from 2·2% to 51·8%, and 0·06 microfilariae per snip to 2·85 microfilariae per snip, respectively. Despite treatment, the prevalence rate doubled between 2000 and 2005 in two communities. Microfilaria assessment 30 days after ivermectin treatment showed 100% clearance of microfilaria in more than 99% of people. At day 90 after treatment, four of ten communities had significant microfilaria repopulation, from 7·1% to 21·1% of pretreatment counts, rising to 53·9% by day 180.
Ivermectin remains a potent microfilaricide. However, our results suggest that resistant adult parasite populations, which are not responding as expected to ivermectin, are emerging. A high rate of repopulation of skin with microfilariae will allow parasite transmission, possibly with ivermectin-resistant O volvulus, which could eventually lead to recrudescence of the disease.
This article is made available free of charge, as a service to our users.
Please login to access the full article, or register if you do not yet have a username and password.
Already Registered? Please Login
New to TheLancet.com?
TheLancet.com is the online home of:
- The Lancet
- The Lancet Diabetes & Endocrinology
- The Lancet Global Health
- The Lancet Infectious Diseases
- The Lancet Neurology
- The Lancet Oncology
- The Lancet Psychiatry
- The Lancet Respiratory Medicine
Please register to access selected articles for free, personalize and interact with this site. Registration is free, takes no more than two minutes, and offers you many benefits.
a Institute of Parasitology, McGill University, Canada b Noguchi Memorial Institute for Medical Research, University of Ghana, Ghana c Health Research Unit, Ghana Health Services, Ghana d Council for Scientific and Industrial Research, Ghana e Ochocerciasis Control Programme of Ghana, Ghana Correspondence to: Professor R K Prichard, Institute of Parasitology, McGill University, 21111 Lakeshore Road, Sainte Anne-de-Bellevue, QC H9X3V9, Canada
Access this article on ScienceDirect
Visit ScienceDirect to see if you have access via your institution.
Please login above or register
to use this functionality. Registration is free, takes no more than two minutes, and offers you many benefits.